53129 |
2025-10-08 |
: sets |
The clinical drug candidate anle138b binds predominantly to a central cavity in lipidic Ab40 fibrils and modulates fibril formation. |
Anle138b binds predominantly to the central cavity in lipidic A\u03b2\u2084\u2080 fibrils and modulates fibril formation
|
Andrei Leonov, Armin Giese, Benedikt Frieg, Bert L de Groot, Christian Dienemann, Christian Griesinger, Dietmar Riedel, Dirk Matthes, Evgeny Nimerovsky, Gunnar F Schroder, Kai Xue, Karin Giller, Kerstin Overkamp, Loren B Andreas, Marianna Stampolaki, Mookyoung Han, Sergey Ryazanov, Stefan Becker |